{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2018"],"data_sharing_plan":["IPD Sharing (as of April 2021): No"],"condition":["Colon Cancer Stage","Colorectal Neoplasms"],"disease":["Colon Cancer Stage","Colorectal Neoplasms"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2282143"],"location":["Egypt"],"study_start_month":["8"],"keyword":["Celecoxib"],"repository":["ECRIN MDR"],"study_status":["Recruiting"],"additional_accession":[]},"is_claimable":false,"name":"Celecoxib as Adjuvant Therapy to Chemotherapy in Patients With Metastatic Colorectal Cancer","description":"The study aimed at evaluation of anticancer effect of celecoxib as adjuvant therapy to chemotherapy in patients with metastatic colorectal cancer","dates":{"creation":"2018-08-15"},"accession":"2282143","cross_references":{"ClinicalTrials___gov":["NCT03645187"]}}